Abstract
Summary
Surrogacy is a method of assisted reproduction in which the intended parents work with surrogate who carries the baby until birth.
LPI (LP Information)' newest research report, the “Surrogacy Industry Forecast” looks at past sales and reviews total world Surrogacy sales in 2022, providing a comprehensive analysis by region and market sector of projected Surrogacy sales for 2023 through 2029. With Surrogacy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Surrogacy industry.
This Insight Report provides a comprehensive analysis of the global Surrogacy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Surrogacy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Surrogacy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Surrogacy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Surrogacy.
The global Surrogacy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Surrogacy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Surrogacy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Surrogacy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Surrogacy players cover New Hope Fertility Center, IVI-RMA Global, Scanfert AVA Clinic, Bourn Hall Fertility Clinic, Nova IVI Fertility, Ovation Fertility, Bangkok IVF Center, Extraordinary Conceptions and Cardone & Associates Reproductive Medicine & Infertility, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Surrogacy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Intrauterine insemination (IUI)
In-vitro fertilization (IVF)
Others
Segmentation by application
Hospitals
Fertility clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
New Hope Fertility Center
IVI-RMA Global
Scanfert AVA Clinic
Bourn Hall Fertility Clinic
Nova IVI Fertility
Ovation Fertility
Bangkok IVF Center
Extraordinary Conceptions
Cardone & Associates Reproductive Medicine & Infertility
Max Healthcare
Growing Generations
Circle Surrogacy
Morpheus Life Sciences
LPI (LP Information)' newest research report, the “Surrogacy Industry Forecast” looks at past sales and reviews total world Surrogacy sales in 2022, providing a comprehensive analysis by region and market sector of projected Surrogacy sales for 2023 through 2029. With Surrogacy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Surrogacy industry.
This Insight Report provides a comprehensive analysis of the global Surrogacy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Surrogacy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Surrogacy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Surrogacy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Surrogacy.
The global Surrogacy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Surrogacy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Surrogacy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Surrogacy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Surrogacy players cover New Hope Fertility Center, IVI-RMA Global, Scanfert AVA Clinic, Bourn Hall Fertility Clinic, Nova IVI Fertility, Ovation Fertility, Bangkok IVF Center, Extraordinary Conceptions and Cardone & Associates Reproductive Medicine & Infertility, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Surrogacy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Intrauterine insemination (IUI)
In-vitro fertilization (IVF)
Others
Segmentation by application
Hospitals
Fertility clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
New Hope Fertility Center
IVI-RMA Global
Scanfert AVA Clinic
Bourn Hall Fertility Clinic
Nova IVI Fertility
Ovation Fertility
Bangkok IVF Center
Extraordinary Conceptions
Cardone & Associates Reproductive Medicine & Infertility
Max Healthcare
Growing Generations
Circle Surrogacy
Morpheus Life Sciences
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Surrogacy Market Size 2018-2029
2.1.2 Surrogacy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Surrogacy Segment by Type
2.2.1 Intrauterine insemination (IUI)
2.2.2 In-vitro fertilization (IVF)
2.2.3 Others
2.3 Surrogacy Market Size by Type
2.3.1 Surrogacy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Surrogacy Market Size Market Share by Type (2018-2023)
2.4 Surrogacy Segment by Application
2.4.1 Hospitals
2.4.2 Fertility clinics
2.4.3 Others
2.5 Surrogacy Market Size by Application
2.5.1 Surrogacy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Surrogacy Market Size Market Share by Application (2018-2023)
3 Surrogacy Market Size by Player
3.1 Surrogacy Market Size Market Share by Players
3.1.1 Global Surrogacy Revenue by Players (2018-2023)
3.1.2 Global Surrogacy Revenue Market Share by Players (2018-2023)
3.2 Global Surrogacy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Surrogacy by Regions
4.1 Surrogacy Market Size by Regions (2018-2023)
4.2 Americas Surrogacy Market Size Growth (2018-2023)
4.3 APAC Surrogacy Market Size Growth (2018-2023)
4.4 Europe Surrogacy Market Size Growth (2018-2023)
4.5 Middle East & Africa Surrogacy Market Size Growth (2018-2023)
5 Americas
5.1 Americas Surrogacy Market Size by Country (2018-2023)
5.2 Americas Surrogacy Market Size by Type (2018-2023)
5.3 Americas Surrogacy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Surrogacy Market Size by Region (2018-2023)
6.2 APAC Surrogacy Market Size by Type (2018-2023)
6.3 APAC Surrogacy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Surrogacy by Country (2018-2023)
7.2 Europe Surrogacy Market Size by Type (2018-2023)
7.3 Europe Surrogacy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Surrogacy by Region (2018-2023)
8.2 Middle East & Africa Surrogacy Market Size by Type (2018-2023)
8.3 Middle East & Africa Surrogacy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Surrogacy Market Forecast
10.1 Global Surrogacy Forecast by Regions (2024-2029)
10.1.1 Global Surrogacy Forecast by Regions (2024-2029)
10.1.2 Americas Surrogacy Forecast
10.1.3 APAC Surrogacy Forecast
10.1.4 Europe Surrogacy Forecast
10.1.5 Middle East & Africa Surrogacy Forecast
10.2 Americas Surrogacy Forecast by Country (2024-2029)
10.2.1 United States Surrogacy Market Forecast
10.2.2 Canada Surrogacy Market Forecast
10.2.3 Mexico Surrogacy Market Forecast
10.2.4 Brazil Surrogacy Market Forecast
10.3 APAC Surrogacy Forecast by Region (2024-2029)
10.3.1 China Surrogacy Market Forecast
10.3.2 Japan Surrogacy Market Forecast
10.3.3 Korea Surrogacy Market Forecast
10.3.4 Southeast Asia Surrogacy Market Forecast
10.3.5 India Surrogacy Market Forecast
10.3.6 Australia Surrogacy Market Forecast
10.4 Europe Surrogacy Forecast by Country (2024-2029)
10.4.1 Germany Surrogacy Market Forecast
10.4.2 France Surrogacy Market Forecast
10.4.3 UK Surrogacy Market Forecast
10.4.4 Italy Surrogacy Market Forecast
10.4.5 Russia Surrogacy Market Forecast
10.5 Middle East & Africa Surrogacy Forecast by Region (2024-2029)
10.5.1 Egypt Surrogacy Market Forecast
10.5.2 South Africa Surrogacy Market Forecast
10.5.3 Israel Surrogacy Market Forecast
10.5.4 Turkey Surrogacy Market Forecast
10.5.5 GCC Countries Surrogacy Market Forecast
10.6 Global Surrogacy Forecast by Type (2024-2029)
10.7 Global Surrogacy Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 New Hope Fertility Center
11.1.1 New Hope Fertility Center Company Information
11.1.2 New Hope Fertility Center Surrogacy Product Offered
11.1.3 New Hope Fertility Center Surrogacy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 New Hope Fertility Center Main Business Overview
11.1.5 New Hope Fertility Center Latest Developments
11.2 IVI-RMA Global
11.2.1 IVI-RMA Global Company Information
11.2.2 IVI-RMA Global Surrogacy Product Offered
11.2.3 IVI-RMA Global Surrogacy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 IVI-RMA Global Main Business Overview
11.2.5 IVI-RMA Global Latest Developments
11.3 Scanfert AVA Clinic
11.3.1 Scanfert AVA Clinic Company Information
11.3.2 Scanfert AVA Clinic Surrogacy Product Offered
11.3.3 Scanfert AVA Clinic Surrogacy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Scanfert AVA Clinic Main Business Overview
11.3.5 Scanfert AVA Clinic Latest Developments
11.4 Bourn Hall Fertility Clinic
11.4.1 Bourn Hall Fertility Clinic Company Information
11.4.2 Bourn Hall Fertility Clinic Surrogacy Product Offered
11.4.3 Bourn Hall Fertility Clinic Surrogacy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Bourn Hall Fertility Clinic Main Business Overview
11.4.5 Bourn Hall Fertility Clinic Latest Developments
11.5 Nova IVI Fertility
11.5.1 Nova IVI Fertility Company Information
11.5.2 Nova IVI Fertility Surrogacy Product Offered
11.5.3 Nova IVI Fertility Surrogacy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Nova IVI Fertility Main Business Overview
11.5.5 Nova IVI Fertility Latest Developments
11.6 Ovation Fertility
11.6.1 Ovation Fertility Company Information
11.6.2 Ovation Fertility Surrogacy Product Offered
11.6.3 Ovation Fertility Surrogacy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Ovation Fertility Main Business Overview
11.6.5 Ovation Fertility Latest Developments
11.7 Bangkok IVF Center
11.7.1 Bangkok IVF Center Company Information
11.7.2 Bangkok IVF Center Surrogacy Product Offered
11.7.3 Bangkok IVF Center Surrogacy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Bangkok IVF Center Main Business Overview
11.7.5 Bangkok IVF Center Latest Developments
11.8 Extraordinary Conceptions
11.8.1 Extraordinary Conceptions Company Information
11.8.2 Extraordinary Conceptions Surrogacy Product Offered
11.8.3 Extraordinary Conceptions Surrogacy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Extraordinary Conceptions Main Business Overview
11.8.5 Extraordinary Conceptions Latest Developments
11.9 Cardone & Associates Reproductive Medicine & Infertility
11.9.1 Cardone & Associates Reproductive Medicine & Infertility Company Information
11.9.2 Cardone & Associates Reproductive Medicine & Infertility Surrogacy Product Offered
11.9.3 Cardone & Associates Reproductive Medicine & Infertility Surrogacy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Cardone & Associates Reproductive Medicine & Infertility Main Business Overview
11.9.5 Cardone & Associates Reproductive Medicine & Infertility Latest Developments
11.10 Max Healthcare
11.10.1 Max Healthcare Company Information
11.10.2 Max Healthcare Surrogacy Product Offered
11.10.3 Max Healthcare Surrogacy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Max Healthcare Main Business Overview
11.10.5 Max Healthcare Latest Developments
11.11 Growing Generations
11.11.1 Growing Generations Company Information
11.11.2 Growing Generations Surrogacy Product Offered
11.11.3 Growing Generations Surrogacy Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Growing Generations Main Business Overview
11.11.5 Growing Generations Latest Developments
11.12 Circle Surrogacy
11.12.1 Circle Surrogacy Company Information
11.12.2 Circle Surrogacy Surrogacy Product Offered
11.12.3 Circle Surrogacy Surrogacy Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Circle Surrogacy Main Business Overview
11.12.5 Circle Surrogacy Latest Developments
11.13 Morpheus Life Sciences
11.13.1 Morpheus Life Sciences Company Information
11.13.2 Morpheus Life Sciences Surrogacy Product Offered
11.13.3 Morpheus Life Sciences Surrogacy Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Morpheus Life Sciences Main Business Overview
11.13.5 Morpheus Life Sciences Latest Developments
12 Research Findings and Conclusion